Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection

BACKGROUND: Oral vancomycin (125 mg qid) is recommended as treatment of severe Clostridium difficile infection (CDI). Higher doses (250 or 500 mg qid) are sometimes recommended for patients with very severe CDI, without supporting clinical evidence. We wished to determine to what extent faecal level...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzales, Milagros, Pepin, Jacques, Frost, Eric H, Carrier, Julie C, Sirard, Stephanie, Fortier, Louis-Charles, Valiquette, Louis
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022836/
https://www.ncbi.nlm.nih.gov/pubmed/21192802
http://dx.doi.org/10.1186/1471-2334-10-363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022836/
https://www.ncbi.nlm.nih.gov/pubmed/21192802
http://dx.doi.org/10.1186/1471-2334-10-363

Ejemplares similares